In this episode of ChalkTalk, we've asked Prof Flavio Ribichini from Verona and Prof Emanuele Barbato from Rome to share their views on calcium treatment in the past and the current era. Read More >
In the latest ChalkTalk episode, we sat down with Dr. Jonathan Hill, Royal Brompton Hospital, London, to have a discussion about his 5-year journey with coronary IVL. Being involved in the first Disrupt CAD clinical studies... Read More >
In the latest ChalkTalk episode, we sat down with Drs. Suzanne Barron, Dawn Abbott, Nadia Sutton and Alexandra Lansky at the 2022 SCAI Scientific Sessions to discuss some of their key takeaways from the meeting and... Read More >
TOPIC: Coronary Clinical DataCoronary ConferencesCoronary IVLFemale vs. Male OutcomesShockwave C2Treating Different Ca++ Morphologies
In episode #9 of the ChalkTalk podcast, we speak with Alexandra Lansky, MD, FACC, FAHA, FSCAI, FESC, Professor of Medicine in Cardiology, and Director of Yale Cardiovascular Clinical Research Program at Yale University School of Medicine... Read More >
TOPIC: Coronary Clinical DataCoronary ConferencesCoronary IVLFemale vs. Male OutcomesShockwave C2SWAV NewsTreating Different Ca++ Morphologies
Hear from Shockwave Medical’s CEO, Doug Godshall, on the company being included in Fast Company’s 2022 list of the world’s “Most Innovative Companies.”  Coronary Important Safety Information: In the United States: Rx only. Indications for Use—The... Read More >
TOPIC: IVL TechnologySWAV News
In the latest ChalkTalk podcast, we’re going to listen in on a sponsored discussion that took place with TCTMD during TCT21 about new insights on the latest Coronary IVL data that was presented during the meeting... Read More >
TOPIC: Coronary Clinical DataCoronary ConferencesCoronary IVLFemale vs. Male OutcomesShockwave C2SWAV NewsTreating Different Ca++ Morphologies

Ready to Make Waves with Shockwave IVL?

Looking for careers? Click here.